Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Air Force invention kills toxins on contact

Image of Man in white coat doing experiments. The Air Force is licensing patent rights to a disease-control coating additive to a private-sector company who wants to put the formula in paint and other products. The formula was invented by Dr. Jeff Owens, a senior chemist with the Air Force Civil Engineer Center. Owens developed the technology in collaboration with the Army — collaborative research and development funded by the Defense Threat Reduction Agency, Joint Science and Technology Office under the Chemical and Biological Defense program.

An Air Force invention could be key to reducing the amount of airborne microbes - like viruses, bacteria and mold spores - inside buildings and homes.

In 2009, the U.S. Air Force submitted a patent application for an invention that coats surfaces with a protective finish, killing toxins on contact.

The technology, which was granted a patent in 2013, was invented by Dr. Jeff Owens, a senior chemist with the Air Force Civil Engineer Center at Tyndall Air Force Base in Florida, to support his work in chemical and biological warfare defense. 

Today, the Air Force is licensing the rights to that technology to a private-sector company that wants to use Owens’ patented formula in paints and other products.

“The patented technology is essentially an additive that can be incorporated into coatings for surfaces and textiles to protect against bioaerosols like viruses, bacteria and mold,” Owens said.

Under a Cooperative Research and Development Agreement, Florida-based Theriax is collaborating with members of the Civil Engineer Laboratory at Tyndall to develop next-generation coatings that deactivate biological and chemical weapons for the Air Force. This CRADA will also allow the company to bring this technology to the commercial paint market.

The partnership provides a mutually beneficial opportunity for the company to develop a commercial paint product that the Air Force could one day use to improve quality of life and health for Airmen and their families on base, Owens said.

Mold growth is a regular challenge for coastal installations, but after the destruction of Hurricane Michael in October 2018, the CE Lab, like many base buildings that remained intact, required hefty cleanup and a fresh coat of paint. Salter said the research team used the antimicrobial paint on one wall.

The wall remained mold free for six months before the paint needed a recharge, however, over time the disinfectant charge wears off and the paint needs to be recharged by wiping down the treated surface with a disinfectant. The recharge frequency is largely dependent on the environmental conditions.

The partnership that began before Hurricane Michael is now focused on how its research can help in the fight against COVID-19.

While Owens and the other AFCEC scientists remain focused on mission applications of the technology, Owens acknowledged that commercially available products, like paint, would indirectly support the Air Force mission.

“If COVID-19 has taught us anything, it’s that reducing exposure pathways and lowering the concentration of infectious aerosols inside a room is critical to controlling disease spread,” Owens said. “This paint isn’t a magic bullet, but it could be one tool that helps makes a difference in the fight to protect human health.”

You also may be interested in...

Policy
Mar 25, 2021

Memorandum: #20-003, COVID-19 Medical Coding Policy

.PDF | 436.92 KB

Handout that accompanies the DHA Policy Memorandum about the COVID-19 Medical Coding Policy; updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Type: Memorandum
Policy
Dec 31, 2020

Memorandum: Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

.PDF | 129.54 KB

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

  • Identification #: N/A
  • Type: Memorandum
Policy
Dec 7, 2020

Memorandum: Coronavirus Disease 2019 Vaccine Guidance

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

  • Identification #: N/A
  • Type: Memorandum
Policy
Sep 11, 2015

Instruction: #DODI 6490.13, Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

  • Identification #: DODI 6490.13
  • Type: Instruction
Policy
Oct 31, 2014

Memorandum: Pre-Deployment, Deployment, and Post-Deployment Training, Screening, and Monitoring Guidance for Department of Defense Personnel Deployed to Ebola Outbreak Areas

.PDF | 8.96 MB

Department of Defense personnel (Service members and civilian employees)deployed to Centers for Disease Control and Prevention defined Ebola outbreak areas will complete pre and post-deployment screening and training requirements outlined in this memorandum and supplemented by United States Africa Command (USAFRICOM) guidance.

  • Identification #: N/A
  • Type: Memorandum
Policy
Sep 18, 2012

Instruction: #DODI 6490.11, DOD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

  • Identification #: DODI 6490.11
  • Type: Instruction
Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery